Devices, systems and methods for delivering a prosthetic mitral valve and anchoring device

Information

  • Patent Grant
  • 11974914
  • Patent Number
    11,974,914
  • Date Filed
    Friday, January 22, 2021
    3 years ago
  • Date Issued
    Tuesday, May 7, 2024
    a month ago
Abstract
Prosthetic heart valves and anchors for use with such valves are provided that allow for an improved implantation procedure. In various embodiments, an anchoring device is formed as a coiled or twisted anchor that includes one or more turns that twist or curve around a central axis. One or more arms attached to the frame of the valve guide the anchoring device into position at the native valve as it exits the delivery catheter, and the expandable prosthetic valve is held within the coil of the anchoring device. The anchoring device and the valve can be delivered together, simplifying the valve replacement procedure.
Description
BACKGROUND FIELD

Complications of the mitral valve, which controls the flow of blood from the left atrium into the left ventricle of the human heart, have been known to cause fatal heart failure. In the developed world, one of the most common forms of valvular heart disease is mitral valve leak, also known as mitral regurgitation, which is characterized by the abnormal leaking of blood from the left ventricle through the mitral valve and back into the left atrium. This occurs most commonly due to ischemic heart disease when the leaflets of the mitral valve no longer meet or close properly after multiple infarctions, idiopathic and hypertensive cardiomyopathies where the left ventricle enlarges, and with leaflet and chordal abnormalities, such as those caused by a degenerative disease.


In addition to mitral regurgitation, rheumatic disease can lead to mitral narrowing or stenosis. While this has been virtually eliminated in developed countries, it is still common where the quality of living is not as high.


In the course of the last decade many companies have been successful in creating catheter or minimally invasive implantable aortic valves, but such implantation of a mitral valve is more difficult. Patients would be benefited by implanting a device by a minimally invasive surgical procedure employing a small incision or by a catheter implantation such as from the groin. From the patient's point of view, the catheter procedure is very attractive. Many patients who require mitral valve replacement are elderly and an open heart procedure is painful, risky and takes time for recovery. Some patients are not even candidates for such a surgery due to their advanced age and frailty.


SUMMARY

Previous filings (for example, International PCT Publication No. WO 2013/114214, the disclosure of which is hereby incorporated by reference herein) have provided a disclosure on the use of an anchor to attach a mitral valve prosthesis in a patient via a catheter or minimally invasive procedure. The anchor most commonly described in these disclosures is a helical anchor which is first placed near the native mitral valve annulus and then the prosthetic valve is implanted inside the anchor. It would also be possible to add a helical anchor after the prosthetic valve was placed. The helical anchor can be placed to improve the stability of the prosthesis, to prevent rocking or even to control a leak that occurs around the valve. Whether the anchor is placed before or after the valve implant, this creates a two-step procedure for the interventionalist. He or she must first place the anchor, and then place the prosthetic valve, or vice versa.


It would be useful to have devices and methods to combine the anchor delivery with the valve delivery to simplify the procedure. A single surgical procedure can also reduce the impact on the patient.


Embodiments of the present invention include a delivery device and system for delivering a prosthetic mitral valve and an anchoring device, such as a helical anchoring device, and methods thereof. The prosthetic mitral valve and the helical anchoring device can be contained within a catheter that delivers both the prosthetic mitral valve and the helical anchoring device to a mitral position of a patient in a single procedure.


According to an embodiment of the invention, a mitral valve prosthesis includes an expandable valve frame and a plurality of arms each connected to the valve frame at or near a first end of the valve frame. A first arm from among the plurality of arms has a shape that is different from a shape of each of the other arms. The first arm is configured to guide a helical anchoring device around the valve frame.


According to another embodiment, a mitral valve prosthesis includes an expandable valve frame, a first arm having a first end attached to the valve frame and a second end configured to extend farther radially from a central axis of the valve frame than the valve frame extends from the central axis when the valve frame is in an expanded configuration, and an anchoring device including a coil that defines an inner space. The valve frame is held by the anchoring device when the valve frame is in the expanded configuration in the inner space of the coil.


According to another embodiment, a method for delivering a mitral valve prosthesis to a native mitral valve of a heart includes positioning a catheter at the native mitral valve, advancing an arm and a first end of a valve frame out of the catheter to a left ventricle of the heart, advancing an anchoring device out of the catheter into the left ventricle around leaflets and chordae tendineae of the native mitral valve, wherein the anchoring device is guided by at least a portion of the arm during the advancing of the anchoring device, and advancing remaining portions of the valve frame out of the catheter, wherein the valve frame is expanded and held in an inner space defined by a coil of the anchoring device.





BRIEF DESCRIPTION OF THE DRAWINGS

Further features and advantages will become apparent from the description of embodiments using the accompanying drawings. In the drawings:



FIGS. 1A-1B show close-up perspective views of an end of a delivery catheter from which a prosthetic valve and a helical anchoring device are being delivered, according to a first embodiment of the invention.



FIGS. 2A-2F are partial cross-sectional schematic views illustrating a process of employing a delivery system to implant the helical anchoring device and the prosthetic mitral valve in the mitral position of a heart, according to the first embodiment.



FIGS. 3A-3B show close-up perspective views of the end of the delivery catheter from which a prosthetic mitral valve with a modified arm is being delivered, according to a second embodiment.



FIGS. 4A-4B show close-up perspective views of the end of a valve delivery catheter and an adjacent helical anchor delivery catheter from which a prosthetic mitral valve and a helical anchoring device are respectively delivered, according to a further embodiment.



FIG. 4C shows a close-up perspective view of the helical anchoring device and the prosthetic valve of FIGS. 4A-4B after delivery from the adjacent helical anchor delivery catheter and the valve delivery catheter, respectively.





DETAILED DESCRIPTION

Disclosed herein are prosthetic mitral heart valves and anchors for use with such valves that allow for a simplified and improved implantation. In various embodiments, a helical anchoring device is formed as a coiled or twisted anchor that includes one or more turns that twist or curve around a central axis. The prosthetic mitral valve is expanded and held within the coil. The anchor and the valve can be delivered in a single procedure. By combining anchor placement with valve implantation, the patient benefits from a faster and simpler prosthetic valve implantation process.



FIGS. 1A-1B show close-up perspective views of an end of a delivery catheter 10 from which a prosthetic valve 4 and a helical anchoring device 5 are being delivered, according to a first embodiment of the invention. For clarity, structures of the heart have been omitted in these figures.



FIG. 1A shows the prosthetic valve 4 with a portion extending from the delivery catheter 10, and a portion that is still being held in the delivery catheter 10. The prosthetic valve 4 includes a valve frame 48 that is expandable from a collapsed position or configuration in which a diameter of the valve frame 48 is reduced to an expanded position or configuration in which the diameter of the valve frame 48 is increased. The valve frame 48 can be collapsed to facilitate delivery through the delivery catheter 10, and can be expanded during or after placement at a native mitral valve, in order to engage the mitral valve annulus or an anchoring device 5 placed at the mitral position, as will be discussed in greater detail below. The valve frame 48 further houses a plurality of leaflets 41 (e.g., as shown in FIG. 2F) for regulating or controlling blood flow through the prosthetic valve 4.


The prosthetic valve further includes a plurality of arms 43 that are attached to the valve and extend from the valve frame 48. The arms 43 can be attached to a distal end of the valve frame 48, so that the arms 43 begin exiting the catheter 10 prior to the valve frame 48 during delivery of the prosthetic valve 4. Alternatively, the arms 43 can be attached higher up towards a center the valve frame 48, away from the distal end (e.g., as seen in FIG. 2F). The arms 43 are curved, with a first portion that extends distally away from the end of the valve frame 48, and a second portion that curves back up towards the valve frame 48 and extends radially outwardly of the valve frame 48. The second portion of the arms 43 will generally extend radially outwardly farther than the valve frame 48 even after the valve frame 48 has been expanded. The arms 43 are shaped in this manner to facilitate positioning around the native mitral valve leaflets.


At least one of the arms 43 is arranged differently (e.g., having a different shape) than the other arms 43. FIG. 1A shows a loop 42 at a distal end of the leftmost illustrated arm 43. The loop 42 is formed by further bending the end of the arm to define a circular opening. A size of the opening defined by the loop 42 is such that the helical anchoring device 5 can pass through and be guided through the loop 42. The loop 42 may also be slightly larger, in order to also hold and/or guide a helical anchor delivery catheter 11 through which the helical anchoring device 5 is deployed. The loop 42 allows the helical anchor delivery catheter 11 to swivel and to be adjusted into a desired delivery position.


The helical anchor delivery catheter 11 is used to deploy and position the helical anchoring device 5. The helical anchor delivery catheter 11 can initially be threaded through or held in the loop 42 of the prosthetic valve 4 during delivery of the prosthetic valve 4 through the catheter 10. In this manner, the deployment of the arms 43 will naturally also bend and/or otherwise position the helical anchor delivery catheter 11 into or close to the desired position for delivery of the helical anchoring device 5. In other embodiments, the helical anchor delivery catheter can alternatively be guided to and through the loop 42 after the respective parts have been delivered from the catheter 10. In the embodiment shown in FIGS. 1A and 1B, the helical anchor delivery catheter 11 is positioned in and passes through the prosthetic valve 4 in the catheter 10. However, in other embodiments, the helical anchor delivery catheter 11 can instead be positioned beside the prosthetic valve 4 (i.e., parallel to prosthetic valve 4) in the catheter 10, or for example can be positioned entirely outside of the catheter 10, as shown in and as will be later discussed with respect to FIGS. 4A-4B.


In some embodiments, the helical anchor delivery catheter 11 can have a preformed shape that facilitates the positioning of the helical anchor delivery catheter 11 once delivered from the delivery catheter 10. In some embodiments, the helical anchor delivery catheter 11 can be steerable through one of various means.



FIGS. 1A and 1B show an initial process of the helical anchoring device 5 being pushed out or otherwise delivered from the helical anchor delivery catheter 11. As will be discussed in greater detail below, the helical anchoring device 5 is formed as a coiled or twisted anchor that includes one or more turns that twist or curve around a central axis. The helical anchoring device 5 defines a generally circular or cylindrical inner space in which the valve frame 48 of the prosthetic valve 4 can expand and be held. The helical anchoring device 5 can be preformed to have the coiled or twisted shape, and is made of or includes a material that allows the helical anchoring device 5 to be deformed (e.g., straightened) when it is held in the helical anchor delivery catheter 11, and where the anchoring device 5 reverts back to its coiled shape when the anchoring device 5 is delivered from the helical anchor delivery catheter 11. The size and/or radius of curvature of the helical anchoring device 5, and the positioning of the helical anchoring delivery catheter 11, is such that the anchoring device 5 can be guided entirely around the native mitral valve leaflets and chordae tendineae when the anchoring device 5 is being deployed. FIG. 1A shows the beginning stages of deployment of the anchoring device 5, where only a distal tip of the anchoring device 5 extends from the helical anchoring delivery catheter 11, while FIG. 1B shows the anchoring device 5 being deployed almost one complete revolution around the valve frame 48 of the prosthetic valve 4. Implantation of the both the prosthetic valve 4 and the anchoring device 5 with respect to the various features of the heart will be discussed in greater detail with respect to FIGS. 2A-2F below.



FIGS. 2A-2F show a delivery system 100 and a method for positioning the prosthetic mitral valve 4 and the helical anchoring device 5 at the native mitral valve 3 of a patient's heart 2 according to the first embodiment.



FIG. 2A shows the delivery system 100 including a catheter 1 which has been advanced in the heart 2 through a peripheral vein, for example, the inferior vena cava 21, into the right atrium 22, across the atrial septum 23 to the left atrium 24 and through the native mitral valve 3 such that the end of the catheter 1 sits in the left ventricle 25 near the native mitral valve 3. The catheter 1 can be introduced into a patient's venous system by percutaneous puncture or by a small surgical cut down at the patient's groin, as is commonly known. Alternatively, the catheter 1 can be introduced anywhere in the lower abdomen or retroperitoneal region, or in the neck or shoulder regions through the subclavian or axillary veins or the jugular system in the neck. In further embodiments, the catheter 1 can be introduced through the superior vena cava 26 or can enter the heart 2 directly through an outer wall of the left atrium 24. As shown in FIG. 2A, the delivery catheter 10 extends from the catheter 1 and is positioned in the left ventricle 25.


The catheter 10 contains or holds the prosthetic mitral valve 4 that can be implanted in the region of the patient's native mitral valve 3, as shown in FIGS. 2E-2F. The prosthetic valve 4 is expandable as previously discussed, and can be self-expanding. Nitinol is typically used to create the valve frame 48 of the self-expanding prosthetic valve 4, but other shape memory materials can be used as well. The valve frame houses artificial leaflets 41, as shown in FIG. 2F, which are typically made from cow or pig pericardium. The leaflets 41 can also be synthetic or derived from other sources such as human cadavers or by biologic tissue engineering. One biologic material which has favorable properties is tissue derived from small intestinal mucosa.



FIG. 2B shows a close up view of the catheter 1 located inside the left heart 27 with the tip 12 of the delivery catheter 10 just below the native leaflets 31 of the mitral valve 3. A portion of the prosthetic valve 4 has been delivered (e.g., deployed outwardly) from the delivery catheter 10 within the left ventricle 25 such that the loop 42 protrudes from the tip 12 of the delivery catheter 10.



FIG. 2C shows the further delivery of the prosthetic mitral valve 4 from the delivery catheter 10. The arms 43 extend from or near the end of the valve frame 48 of the prosthetic valve 4 that sits in the left ventricle 25, and wrap around the native leaflets 31 and serve to anchor the prosthetic valve 4 firmly against the margins of the native mitral leaflets 31. The arrows illustrate the direction in which the arms 43 wrap around the lower margin of the native mitral leaflets 31 after the arms 43 have been outwardly deployed from the delivery catheter 10. The arms 43 will help prevent the prosthetic valve 4 from dislodging upward into the left atrium 24 when the prosthetic valve 4 is fully positioned.


A number of arms 43 are useful to provide a lower plane of attachment of the prosthetic mitral valve 4 to the native mitral valve 3. The arms 43 can vary in length and in character and construction. It will be understood that more or less than two arms 43 can be used with this embodiment, even though only two arms are shown in FIGS. 2A-2F for the purposes of illustration.


One of the arms 43 has the loop 42 at its far or distal end to direct or control a helical anchor delivery catheter 11 that contains the helical anchoring device 5. In this embodiment, the helical anchor delivery catheter 11 has been preloaded into the loop 42. The arm 43 including the loop 42 can be of heavier construction than the other arms 43 and does not have to resemble the other arm or arms 43 that do not include a loop 42.


The arms 43 have shape memory properties or are otherwise resilient, such that when they are deployed outwardly from the delivery catheter 10 they can revert back to their curved shapes and wrap around the native mitral leaflets 31.


The arm 43 with the loop 42 wraps around the native mitral leaflet 31 and the attached helical anchor delivery catheter 11 is carried with it so that the chordae tendineae 32 and the patient's mitral valve leaflets 31 sit inside (i.e., on a concave side of the curvature of) an exposed end of the helical anchoring device 5. When the helical anchoring device 5 is advanced from this location, it will encircle the chordae tendineae 32 so that the native mitral valve leaflets 31 and the chordae 32 will be trapped inside a circle created by the helical anchoring device 5, as will be seen later.


The loop 42 at the end of the arm 43 swings the helical anchor delivery catheter 11 around the leaflets 31 and above the chordae 32 into a preferred position under the native mitral valve annulus 34. This particular arm 43 can have a double function of attaching the prosthetic valve 4 to the leaflet margin and guiding delivery of the helical anchoring device 5. The loop 42 can be sufficiently large to allow the helical anchor delivery catheter 11 to pivot or swivel as the system is deployed.


The helical anchoring device 5 is preferably delivered in a plane close to parallel to the underside of the native mitral valve 3. The helical anchor delivery catheter 11 is also aimed or directed to this plane by the loop 42. In one embodiment, the loop 42 can include a short tube that forces the helical anchor delivery catheter 11 into a favorable plane and orientation. Or the helical anchor delivery catheter 11 can be steerable. Many steerable catheters are known and available in the field of art.


In further embodiments, devices other than the loop 42 can direct the delivery of the helical anchoring device 5. For example, a cell of a stent frame that composes part of the prosthetic mitral valve 4 can also perform the same function as the loop 42 shown here. A hook or a tube can also be used. Any structure that can direct the helical anchoring device 5 around the native leaflets 31 can be added to the prosthetic valve 4. The structure can be permanently fabricated in the prosthetic valve 4 or can be temporary. For example, a loop of suture could be used to create the loop 42. The suture could then be withdrawn. In other embodiments, prior mitral valve prosthetics having arms or wings can be modified or retrofitted with the loop 42 of the present prosthetic valve 4 in order to facilitate delivery of the helical anchoring device 5.


The arms 43 in FIGS. 2C-2F can be quite slender. In practice, the arms 43 can be composed of pairs or triplets of wires that are fused at the ends 45 of the arms 43. These narrow terminal ends 45 to the arms 43 facilitate the arms 43 passing between the chordae tendineae 32 at their margin with the free edges 33 of the mitral leaflets 31 to allow the arms 43 to wrap around the leaflets 31. The chordae 32 are closely packed around some areas of the native mitral valve 3, and slender arms 43 will better facilitate passing of the arms 43 between the chordae tendineae 32. Once the slender part of the arms 43 pass, thicker parts of the arms 43 can move between the chordae 32 by spreading them apart. Thus, in some embodiments, the arm 43 is slender (or composed of a single wire or a fusion of wires) at the tip 45 and is more robust closer to the main body of the prosthetic valve 4 (for more powerful attachment). Further, the arms 43 can also be shorter or longer than illustrated in FIGS. 2C-2F.


Deployment of the helical anchoring device 5 can be started anywhere around the mitral valve annulus 34. For example, deployment of the helical anchoring device 5 can start in or adjacent to the middle of a leaflet 31. This would be an advantage for an operator who, for example, would not have to precisely locate a commissure of the native mitral valve to begin the anchoring device delivery procedure, thereby simplifying the procedure.



FIG. 2D shows a close-up schematic view of the helical anchoring device 5 being delivered under the native mitral valve leaflets 31 at the mitral position. The arrow illustrates the direction in which the helical anchoring device 5 is deployed from the delivery catheter 11 under the native mitral valve 3. Any number of turns can be delivered depending on the particular helical anchoring device 5 used. An inner diameter of the helical anchoring device 5 can preferentially be slightly less than an outer diameter of the fully expanded mitral prosthetic valve 4 in order to promote engagement between the helical anchoring device 5 and the prosthetic valve 4.


The partially delivered prosthetic valve 4 can serve to center the delivery of the helical anchoring device 5. It can also provide a stable platform for delivery of the helical anchoring device 5.


In the embodiment illustrated in FIG. 2E, three turns of the helical anchoring device 5 have been placed below the native mitral valve 3. The native mitral valve leaflets 31 are positioned between the helical anchoring device 5 and the prosthetic mitral valve 4, which is shown in FIG. 2E as being about to expand. Once the prosthetic valve 4 is expanded, the helical anchoring device 5 aids in securely positioning the prosthetic valve 4 and prevents leaks around the prosthetic valve 4 by sealing the native leaflets 31 to or against the prosthetic valve 4. Opposing forces between the helical anchoring device 5 and the prosthetic valve 4 help position and stabilize the prosthetic valve 4.


In FIG. 2E, the delivery catheter 10 has been omitted for simplicity. In practice, the prosthetic valve 4 would spring open in FIG. 2E when the delivery catheter 10 has been removed (the arrows indicate the direction in which the prosthetic valve 4 would normally spring open). However, in FIG. 2E the prosthetic valve 4 is still in a closed position in order to allow clear visualization of the turns of the helical anchoring device 5 under the native mitral valve 3. In this embodiment, the prosthetic valve 4 further includes an expandable atrial portion 46 that extends or projects from or near a second end of the valve frame 48 opposite the end from which the arms 43 extend. The atrial portion 46 is configured to be held against or to abut against a wall of the left atrium 24, to help further stabilize the prosthetic valve 4 at the mitral position. The atrial portion 46 of the prosthetic valve 4 can expand to a size greater than the mitral valve annulus 34, for example, to restrict movement of the prosthetic valve 4 into the left ventricle 25.


In the embodiment of FIG. 2E, there are three turns of the helical anchoring device 5, but any number of turns can be used. The turns sit up against the underside of the mitral valve annulus 34 and the leaflets 31 in order to provide a solid buttress to fix the helical anchoring device 5 in position and to prevent movement of the prosthetic valve 4 into the left atrium 24 when the left ventricle 25 contracts. Since the arms 43 are wrapped around the helical anchoring device 5, the entire structure is stabilized in position.


The use of a helical anchoring device that can optionally be delivered at the same time as a prosthetic valve provides the interventionalist a considerable amount of choice. For example, some embodiments of the prosthetic valve 4 are able to be re-sheathed, i.e., re-inserted into the delivery catheter 10, allowing the prosthetic valve 4 to be partly advanced and tested for its fit during a procedure. If the operator is not happy with the positioning before the final release of the prosthetic valve 4, the prosthetic valve 4 can be pulled back into the delivery catheter 10.


In some methods of use, the prosthetic valve 4 can be positioned first without the helical anchoring device 5 in place. If the anchoring of the prosthetic valve 4 appears to be strong and stable and there is no evidence of movement or leak, the prosthetic valve 4 can be released without the helical anchoring device 5. On the other hand, if the operator is not satisfied with, for example, the position or stability of the prosthetic valve 4 in the mitral position without the helical anchoring device 5, the prosthetic valve 4 can be pulled back into the delivery catheter 10. Then, the helical anchoring device 5 can be placed first and the prosthetic valve 4 can be positioned and expanded therein. This would let the user decide the clinical need for the extra anchoring of the helical anchoring device 5 based on each individual procedure.


In FIG. 2F, the fully implanted prosthetic valve 4 is shown in the mitral position. The arms 43 have wrapped around the native mitral valve leaflets 31 to prevent the prosthetic valve 4 from moving upward into the left atrium 24. The native mitral leaflets 31 are compressed tightly under the arms 43 and a solid mechanical structure has been created to prevent the prosthetic valve 4 from migrating.


The turns of the helical anchoring device 5 also compress against the body of the prosthetic valve 4 to position, orient and prevent movement of the prosthetic valve 4. The helical anchoring device 5 provides a frictional attachment of the body of the prosthetic valve 4 to the native mitral valve leaflets 31 and serves to anchor the arms 43 that wrap around the helical anchoring device 5.


The upper atrial portion 46 of the prosthetic mitral valve 4 is shown with a wide area that sits inside the left atrium 24 to promote attachment to or abutment against the wall of the left atrium 24. However the force or pressure that tends to urge the prosthetic mitral valve 4 from the left atrium 24 into the left ventricle 25 is low, and so the atrial portion 46 may not be necessary and could be eliminated or reduced in a clinical prosthesis according to some embodiments.


The turns of the helical anchoring device 5 aid in overcoming variations in the lengths of the patient's leaflets 31, variations in the length of the chordae tendineae 32 and variations in the attachment point of the chordae 32 in the left ventricle 25. When a prosthetic mitral valve with arms 43 wrapping around the leaflets 31 is used without any helix or anchor encircling under the leaflets 31, the depth or robustness of fixation of the prosthetic mitral valve can vary around the perimeter of the implanted prosthetic mitral valve. For example, if the chordae tendineae 32 attached to the middle part of the posterior leaflet 31 were very elongated or ruptured (a common situation), the arms 43 can fail to wrap around and engage the leaflet 31 at this location. Or there can be a very limited engagement between one of the arms 43 and the leaflet 31, causing the arm 43 to move to or come to rest at a much higher plane closer to the valve annulus 34. If any of these occurs, the part of the prosthetic valve where this happens would sit higher or closer to the native mitral valve 3, which may create a skew in the prosthetic valve so the prosthetic valve would sit at an angle to the plane of inflow of the valve. As the heart beats, there is a large load on the prosthetic valve and it can begin to rock and shift. The heart beats almost 100,000 times per day and after several days or weeks or months, the prosthetic valve may shift, move and dislodge. Also, if the leaflets 31 or chordae 32 were very elongated, there may be no contact with the arms, and an effective seal around the implant may not be formed. This could result in a large paravalvular leak due to lack of engagement of the prosthetic valve with the native mitral leaflets 31. The helical anchoring device 5 under the leaflets 31 can compress leaflet tissue against the prosthetic valve and prevent this problem. The helical anchoring device 5 can sit in one plane and prevent problems related to variations in patient anatomy.


In clinical practice, there are virtually limitless variations in the size of the leaflets 31, the character of the leaflets 31, the chordal lengths and the attachment of chordae 32 as well as the diameter of the mitral annulus 34. The use of the helical anchoring device 5 under the leaflets 31 neutralizes many of these variables since the fixation point of the arms 43 can be brought to the lowest turn of the helical anchoring device 5. This position can be determined in advance by selecting the number of turns of the helical anchoring device 5 and the thickness of the helical anchoring device 5 to match the turning point of the arms 43 at the lowest part of the prosthetic valve 4.


Thus, the helical anchoring device 5 can create a common and predefined plane for the anchoring of the arms 43 of the prosthetic mitral valve 4. In the situation described previously where some of the chordae 32 are stretched and where contact between the prosthetic valve 4 may otherwise be loose or less secure without the helical anchoring device 5, the attachment of the prosthetic mitral valve 4 in this region can be to the helical anchoring device 5 instead. This would create a common plane for the lowest point of the prosthetic mitral valve 4.


Therefore, more turns of the helical anchoring device 5 can be added to ensure the arms 43 of the prosthetic valve 4 are at a common lowest plane throughout its perimeter. In some embodiments, the helical anchoring device 5 can be made thicker. In some embodiments, waves or undulations can be added to the turns of the helical anchoring device 5 to expand the height of the helical anchoring device 5.


The helical anchoring device 5 thus improves stability of the prosthetic valve 4 by providing an anchor point for the arms 43 of the prosthetic valve 4 to wrap around and at the same time the helical anchoring device 5 can trap the perimeter of the barrel of the prosthetic valve 4 along its length. The combination of these features provides great stability to the prosthetic valve 4. It also seals the native mitral valve 3 against the prosthetic valve 4 to prevent a paravalvular leak.


In addition, patients' native mitral valves (i.e., leaflets 31, annulus 34, and chordae 32) come in all varieties and combinations. It is less practical for a manufacturer to make different lengths and depths of anchoring arms 31 and for the operator to deliver these products perfectly into position inside the patient. It can be more practical to adjust for these variations by placing the helical anchoring device 5 below the prosthetic valve 4 and using this helical anchoring device 5 to create a lowest plane for the arms 43 to anchor against.



FIGS. 3A-3B show the end of the delivery catheter 10 from which a prosthetic valve 4′ is being delivered, according to a second embodiment. For clarity, structures of the heart 2 have been omitted in these figures.


In the embodiments described above, the helical anchor delivery catheter 11 that delivers the helical anchoring device 5 under the native mitral leaflets 31 is separate from the prosthetic device 4. In the embodiment illustrated in FIGS. 3A-3B, the helical anchor delivery catheter has been incorporated into the prosthetic valve 4′ as a modified arm 43′. The prosthetic valve 4′ includes the modified arm 43′ that wraps around one of the mitral leaflets 31, similar to the other arms 43. Here, the modified arm 43′ is a hollow tube that can be loaded with the helical anchoring device 5, and which is sized so that the helical anchoring device can be advanced therethrough. The modified arm 43′ includes a bend 47 and a portion at a distal end that is angled relative to the rest of the arm 43′, so that a distal portion of the arm 43′ extends circumferentially around the prosthetic valve 4′. An opening of the hollow tube therefore points circumferentially around the prosthetic valve 4′ to help direct the helical anchoring device 5 around the native mitral leaflets 31 and the chordae 32. However, any structure on the modified arm 43′ of the prosthetic valve 4′ or any part of the prosthetic valve 4′ that could guide the helical anchoring device 5 can suffice to direct the helical anchoring device 5 into the correct position. When the modified arm 43′ wraps around one of the mitral leaflets 31, the helical anchoring device 5 is carried into the correct location and to the correct plane for delivery. The modified arm 43′ can be preformed and made of a shape-memory material, such as nitinol.



FIG. 3B shows almost one complete turn of the helical anchoring device 5 extending from the tubular arm 43′. As described above, the helical anchoring device 5 can complete multiple turns under or around the native mitral leaflets 31. As shown in this embodiment, the prosthetic mitral valve can be modified to carry the helical anchoring device 5 without the need for a separate helical anchor delivery catheter positioned under or around the native mitral leaflets 31.



FIGS. 4A-4B show close-up perspective views of the end of the delivery catheter 10 and an adjacent helical anchor delivery catheter 11″.


In the embodiment shown in FIGS. 1A-1B, the helical anchor delivery catheter 11 is positioned inside the prosthetic mitral valve 4 in the catheter 10. However, in this embodiment, the helical anchor delivery catheter 11″ and the prosthetic valve 4″ are delivered side by side. As shown in FIGS. 4A-4B, the prosthetic valve 4 can be constructed similarly to the prosthetic valve 4 in the embodiment of FIGS. 1A-1B. The helical anchor delivery catheter 11″ is instead positioned outside the delivery catheter 10 that delivers the prosthetic mitral valve 4″. The helical anchor delivery catheter 11″ passes through the loop 42 in one of the arms 43 in the prosthetic mitral valve 4″. The arrows adjacent the helical anchoring device 5 demonstrate the direction in which the helical anchoring device 5 is being delivered from the end of the helical delivery catheter 11″.



FIG. 4B shows the helical anchoring device 5 further extended from the helical anchor delivery catheter 11″. The end of the helical anchor delivery catheter 11″ is still in the loop 42 at the end one of the arms 43, and almost one full turn of the helical anchoring device 5 has been delivered.



FIG. 4C shows a close-up perspective view of the helical anchoring device 5 and the prosthetic valve 4″ of FIGS. 4A-4B after delivery from the helical anchor delivery catheter 11″ and the delivery catheter 10, respectively.


In FIG. 4C, about three turns of the helical anchoring device 5 have been delivered under the schematically illustrated plane 35 of the native mitral valve 3. However, any number of turns of the helical anchoring device 5 can be provided in order to provide support to the prosthetic valve 4″. The helical anchor delivery catheter 11″ has been removed in FIG. 4C for simplicity. The delivery catheter 10 delivering the prosthetic valve 4″ has also been removed. As discussed regarding FIG. 2E above, the body of the prosthetic valve 4″ would generally spring open when the delivery catheter 10 is removed. But for the purpose of illustration, the prosthetic valve 4″ is shown in FIG. 4C in its closed position to make visualization of the helical anchoring device 5 and the prosthetic valve 4″ clearer.


Various other modifications or alternative configurations can be made to the prosthetic valves, helical anchors, and/or deployment systems according to the above described embodiments of the invention. For example, any variation of the valve prosthesis where controlled deployment of a helical anchor can be facilitated by a portion of the prosthesis that interacts with either the helical anchor itself or with a catheter for delivering the helical anchor may be alternatively arranged. The interacting feature may be embodied in an arm of the valve prosthesis as described in some of the above embodiments, or may be a feature that is arranged on another portion of the valve prosthesis. With respect to the helical anchor, the number of coils can be further varied, based on for example, properties of the native mitral valve and/or desired positioning of the valve prosthesis. Various other coil shapes, lengths, and arrangements and modifications can also be made based on a wide range of considerations.


For purposes of this description, certain aspects, advantages, and novel features of the embodiments of this disclosure are described herein. The disclosed methods, apparatus, and systems should not be construed as being limiting in any way. Instead, the present disclosure is directed toward all novel and nonobvious features and aspects of the various disclosed embodiments, alone and in various combinations and sub-combinations with one another. The methods, apparatus, and systems are not limited to any specific aspect or feature or combination thereof, nor do the disclosed embodiments require that any one or more specific advantages be present or problems be solved.


Although the operations of some of the disclosed embodiments are described in a particular, sequential order for convenient presentation, it should be understood that this manner of description encompasses rearrangement, unless a particular ordering is required by specific language set forth below. For example, operations described sequentially may in some cases be rearranged or performed concurrently. Moreover, for the sake of simplicity, the attached figures may not show the various ways in which the disclosed methods can be used in conjunction with other methods. Additionally, the description sometimes uses terms like “provide” or “achieve” to describe the disclosed methods. These terms are high-level abstractions of the actual operations that are performed. The actual operations that correspond to these terms may vary depending on the particular implementation and are readily discernible by one of ordinary skill in the art.


In view of the many possible embodiments to which the principles of the disclosure may be applied, it should be recognized that the illustrated embodiments are only preferred examples and should not be taken as limiting the scope of the disclosure. Rather, the scope of the disclosure is defined by the following claims.

Claims
  • 1. A valve prosthesis configured to be implanted at a native valve of a heart, comprising: an expandable prosthetic valve frame;a first arm connected to and extending from a first end of the valve frame;a second arm connected to and extending from the first end of the valve frame;wherein the entire first arm and the entire second arm are shaped differently from one another; andan anchoring device comprising a coil configured to define an inner space for receiving the valve frame, wherein only one of the first arm or the second arm is configured to deploy and guide the anchoring device around the valve frame.
  • 2. The valve prosthesis of claim 1, wherein the first arm differs from the second arm in that the first arm comprises a closed annulus that defines an opening through which an anchoring device is guided.
  • 3. The valve prosthesis of claim 1, wherein the first arm differs from the second arm in that the first arm comprises a hollow tube through which an anchoring device is guided.
  • 4. The valve prosthesis of claim 1, wherein the first arm is of a heavier construction than the second arm.
  • 5. The valve prosthesis of claim 1, further comprising at least a third arm having a same shape as the second arm.
  • 6. The valve prosthesis of claim 1, wherein the valve frame houses a plurality of prosthetic valve leaflets.
  • 7. A valve prosthesis configured to be implanted at a native valve of a heart, comprising: an expandable prosthetic valve frame having a central axis;an arm connected to the valve frame; andan anchoring device comprising a coil configured to define an inner space for receiving the valve frame, wherein the arm is configured to deploy and guide the anchoring device around the valve frame;wherein when the valve prosthesis is implanted at a native valve, the anchoring device is configured to be detached from the arm, and the arm is configured to extend farther away radially from the central axis than the anchoring device extends from the central axis.
  • 8. The valve prosthesis of claim 7, wherein a first portion of the arm extends axially away from a first end of the valve frame and a second portion of the arm extends axially from the first portion back towards the valve frame.
  • 9. The valve prosthesis of claim 7, wherein the arm comprises a closed annulus that defines an opening through which an anchoring device is guided.
  • 10. The valve prosthesis of claim 7, wherein the arm is a first arm, and wherein the valve prosthesis further comprises at least a second arm connected to the valve frame.
  • 11. The valve prosthesis of claim 10, wherein the first arm is of a heavier construction than the second arm.
  • 12. The valve prosthesis of claim 7, wherein the valve frame houses a plurality of prosthetic valve leaflets.
CROSS-REFERENCE TO RELATED APPLICATION

The present disclosure is a continuation of U.S. patent application Ser. No. 16/057,192, filed Aug. 7, 2018, which is a continuation of U.S. patent application Ser. No. 14/628,060, filed Feb. 20, 2015, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/943,125, filed Feb. 21, 2014, the contents of each of the foregoing are incorporated by reference herein in their entirety.

US Referenced Citations (354)
Number Name Date Kind
3564617 Sauvage et al. Feb 1971 A
3755823 Hancock Sep 1973 A
4035849 Angell et al. Jul 1977 A
4490859 Black et al. Jan 1985 A
4512338 Balko et al. Apr 1985 A
4759758 Gabbay Jul 1988 A
4777951 Cribier et al. Oct 1988 A
4787899 Lazarus Nov 1988 A
4790843 Carpentier et al. Dec 1988 A
4796629 Grayzel Jan 1989 A
4856516 Hillstead Aug 1989 A
4878495 Grayzel Nov 1989 A
4966604 Reiss Oct 1990 A
4994077 Dobben Feb 1991 A
5059177 Towne et al. Oct 1991 A
5192297 Hull Mar 1993 A
5282847 Trescony et al. Feb 1994 A
5370685 Stevens Dec 1994 A
5403305 Sauter et al. Apr 1995 A
5411552 Andersen et al. May 1995 A
5443500 Sigwart Aug 1995 A
5545214 Stevens Aug 1996 A
5554185 Block et al. Sep 1996 A
5558644 Boyd et al. Sep 1996 A
5584803 Stevens et al. Dec 1996 A
5591195 Taheri et al. Jan 1997 A
5607464 Trescony et al. Mar 1997 A
5665115 Cragg Sep 1997 A
5769812 Stevens et al. Jun 1998 A
5800508 Goicoechea et al. Sep 1998 A
5840081 Andersen et al. Nov 1998 A
5855597 Jayaraman Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5925063 Khosravi Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
6027525 Suh et al. Feb 2000 A
6120534 Ruiz Sep 2000 A
6168614 Andersen et al. Jan 2001 B1
6221091 Khosravi Apr 2001 B1
6235042 Katzman May 2001 B1
6245102 Jayaraman Jun 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6306141 Jervis Oct 2001 B1
6406492 Lytle Jun 2002 B1
6409758 Stobie et al. Jun 2002 B2
6419696 Ortiz et al. Jul 2002 B1
6425916 Garrison et al. Jul 2002 B1
6432134 Anson et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6482228 Norred Nov 2002 B1
6527979 Constantz Mar 2003 B2
6582462 Andersen et al. Jun 2003 B1
6625578 Spaur et al. Sep 2003 B2
6652578 Bailey et al. Nov 2003 B2
6730118 Spenser et al. May 2004 B2
6730121 Ortiz et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6767362 Schreck Jul 2004 B2
6797002 Spence et al. Sep 2004 B2
6830584 Seguin Dec 2004 B1
6878162 Bales et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6971998 Rosenman et al. Dec 2005 B2
7018406 Seguin et al. Mar 2006 B2
7018408 Bailey et al. Mar 2006 B2
7037334 Hlavka et al. May 2006 B1
7077861 Spence Jul 2006 B2
7101395 Tremulis et al. Sep 2006 B2
7125421 Tremulis et al. Oct 2006 B2
7166126 Spence et al. Jan 2007 B2
7166127 Spence et al. Jan 2007 B2
7276078 Spenser et al. Oct 2007 B2
7276084 Yang et al. Oct 2007 B2
7318278 Zhang et al. Jan 2008 B2
7374571 Pease et al. May 2008 B2
7393360 Spenser et al. Jul 2008 B2
7404824 Webler et al. Jul 2008 B1
7431726 Spence et al. Oct 2008 B2
7445632 McGuckin, Jr. et al. Nov 2008 B2
7462191 Spenser et al. Dec 2008 B2
7510575 Spenser et al. Mar 2009 B2
7527646 Rahdert et al. May 2009 B2
7585321 Cribier Sep 2009 B2
7618446 Andersen et al. Nov 2009 B2
7618449 Tremulis et al. Nov 2009 B2
7637946 Solem et al. Dec 2009 B2
7655034 Mitchell et al. Feb 2010 B2
7708775 Rowe et al. May 2010 B2
7737060 Strickler et al. Jun 2010 B2
7758639 Mathis Jul 2010 B2
7780726 Seguin Aug 2010 B2
7785366 Maurer et al. Aug 2010 B2
7942927 Kaye et al. May 2011 B2
7951195 Antonsson et al. May 2011 B2
7955385 Crittenden Jun 2011 B2
7959672 Salahieh et al. Jun 2011 B2
7967857 Lane Jun 2011 B2
7993394 Hariton et al. Aug 2011 B2
8016882 Macoviak et al. Sep 2011 B2
8029556 Rowe Oct 2011 B2
8052750 Tuval et al. Nov 2011 B2
8092520 Quadri Jan 2012 B2
8128691 Keranen Mar 2012 B2
8142492 Forster et al. Mar 2012 B2
8167932 Bourang et al. May 2012 B2
8167935 McGuckin, Jr. et al. May 2012 B2
8236049 Rowe et al. Aug 2012 B2
8323335 Rowe et al. Dec 2012 B2
8377115 Thompson Feb 2013 B2
8398708 Meiri et al. Mar 2013 B2
8449599 Chau et al. May 2013 B2
8449605 Lichtenstein et al. May 2013 B2
8449606 Eliasen et al. May 2013 B2
8652203 Quadri et al. Feb 2014 B2
8657872 Seguin Feb 2014 B2
8663322 Keranen Mar 2014 B2
8672998 Lichtenstein et al. Mar 2014 B2
8685086 Navia et al. Apr 2014 B2
8734507 Keranen May 2014 B2
8795352 O'Beimne et al. Aug 2014 B2
8801776 House et al. Aug 2014 B2
8840664 Karapetian et al. Sep 2014 B2
8986373 Chau et al. Mar 2015 B2
9078747 Conklin Jul 2015 B2
9095434 Rowe Aug 2015 B2
9119718 Keranen Sep 2015 B2
9180006 Keranen Nov 2015 B2
9192471 Bolling Nov 2015 B2
9237886 Seguin et al. Jan 2016 B2
9314335 Konno Apr 2016 B2
9326853 Olson et al. May 2016 B2
9364326 Yaron Jun 2016 B2
9463268 Spence Oct 2016 B2
9474599 Keranen Oct 2016 B2
9526572 Kunis Dec 2016 B2
9597205 Tuval Mar 2017 B2
9622863 Karapetian et al. Apr 2017 B2
9700409 Braido et al. Jul 2017 B2
9867702 Keränen et al. Jan 2018 B2
10016272 Spence et al. Jul 2018 B2
10016276 Brunnett et al. Jul 2018 B2
10034749 Spence et al. Jul 2018 B2
10039637 Maimon et al. Aug 2018 B2
10052198 Chau et al. Aug 2018 B2
10195028 Hosmer et al. Feb 2019 B2
10195033 Tuval et al. Feb 2019 B2
10226339 Spence et al. Mar 2019 B2
10357361 Rafi et al. Jul 2019 B2
10463479 Manash et al. Nov 2019 B2
10828150 Tamir Nov 2020 B2
11020225 Keränen et al. Jun 2021 B2
11039924 Yaron Jun 2021 B2
11065111 Manash et al. Jul 2021 B2
11141273 Dakin et al. Oct 2021 B2
11185406 Haivatov et al. Nov 2021 B2
11364114 Gorman, III et al. Jun 2022 B2
11382748 Keränen et al. Jul 2022 B2
11471282 Argento et al. Oct 2022 B2
11547563 Keränen et al. Jan 2023 B2
11654025 O'Carroll et al. May 2023 B2
11666441 McDaniel et al. Jun 2023 B2
20020026094 Roth Feb 2002 A1
20020032481 Gabbay Mar 2002 A1
20020045936 Moe Apr 2002 A1
20020055773 Campbell et al. May 2002 A1
20020107535 Wei et al. Aug 2002 A1
20020138135 Duerig et al. Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020173841 Ortiz et al. Nov 2002 A1
20030050694 Yang et al. Mar 2003 A1
20030100939 Yodfat et al. May 2003 A1
20030158597 Quiachon et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030212454 Scott et al. Nov 2003 A1
20030225420 Wardle Dec 2003 A1
20040111006 Alferness et al. Jun 2004 A1
20040167620 Ortiz et al. Aug 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040260389 Case et al. Dec 2004 A1
20050096736 Osse et al. May 2005 A1
20050119682 Nguyen et al. Jun 2005 A1
20050119735 Spence et al. Jun 2005 A1
20050137691 Salahieh et al. Jun 2005 A1
20050149178 Spence Jul 2005 A1
20050182486 Gabbay Aug 2005 A1
20050203614 Forster et al. Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050228496 Mensah et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20060020327 Lashinski et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060149350 Patel et al. Jul 2006 A1
20060195134 Crittenden Aug 2006 A1
20060195185 Lane et al. Aug 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20070005131 Taylor Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070010877 Salahieh et al. Jan 2007 A1
20070112422 Dehdashtian May 2007 A1
20070185572 Solem et al. Aug 2007 A1
20070203503 Salahieh et al. Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070232898 Huynh et al. Oct 2007 A1
20070244553 Rafiee et al. Oct 2007 A1
20070265700 Eliasen et al. Nov 2007 A1
20070293808 Williams et al. Dec 2007 A1
20080004697 Lichtenstein et al. Jan 2008 A1
20080021547 Davidson Jan 2008 A1
20080033542 Antonsson et al. Feb 2008 A1
20080077235 Kirson Mar 2008 A1
20080114442 Mitchell et al. May 2008 A1
20080125853 Bailey et al. May 2008 A1
20080140190 Macoviak et al. Jun 2008 A1
20080200977 Paul et al. Aug 2008 A1
20080200980 Robin et al. Aug 2008 A1
20080208327 Rowe Aug 2008 A1
20080208330 Keranen Aug 2008 A1
20080228265 Spence et al. Sep 2008 A1
20080243245 Thambar et al. Oct 2008 A1
20080275503 Spence et al. Nov 2008 A1
20090005863 Goetz et al. Jan 2009 A1
20090088836 Bishop et al. Apr 2009 A1
20090099653 Suri et al. Apr 2009 A1
20090157175 Benichou Jun 2009 A1
20090177278 Spence Jul 2009 A1
20090192601 Rafiee et al. Jul 2009 A1
20090234318 Loulmet et al. Sep 2009 A1
20090259307 Gross et al. Oct 2009 A1
20090276038 Tremulis et al. Nov 2009 A1
20090276040 Rowe et al. Nov 2009 A1
20090281619 Le et al. Nov 2009 A1
20090299471 Keranen Dec 2009 A1
20090319037 Rowe et al. Dec 2009 A1
20100036484 Hariton et al. Feb 2010 A1
20100049313 Alon et al. Feb 2010 A1
20100076548 Konno Mar 2010 A1
20100076549 Keidar et al. Mar 2010 A1
20100145440 Keranen Jun 2010 A1
20100152839 Shandas et al. Jun 2010 A1
20100161047 Cabiri Jun 2010 A1
20100168844 Toomes et al. Jul 2010 A1
20100198347 Zakay et al. Aug 2010 A1
20100217382 Chau et al. Aug 2010 A1
20100217385 Thompson et al. Aug 2010 A1
20100312333 Navia et al. Dec 2010 A1
20100318183 Keranen Dec 2010 A1
20100318184 Spence Dec 2010 A1
20100331971 Keranen et al. Dec 2010 A1
20100331973 Keranen Dec 2010 A1
20110015729 Jimenez et al. Jan 2011 A1
20110098802 Braido et al. Apr 2011 A1
20110106247 Miller et al. May 2011 A1
20110137397 Chau et al. Jun 2011 A1
20110178597 Navia et al. Jul 2011 A9
20110196480 Cartledge Aug 2011 A1
20110208297 Tuval et al. Aug 2011 A1
20110208298 Tuval et al. Aug 2011 A1
20110218621 Antonsson et al. Sep 2011 A1
20110224785 Hacohen Sep 2011 A1
20110245911 Quill Oct 2011 A1
20110288634 Tuval et al. Nov 2011 A1
20110295361 Claiborne, III et al. Dec 2011 A1
20110319989 Lane et al. Dec 2011 A1
20110319990 Macoviak et al. Dec 2011 A1
20120016464 Seguin Jan 2012 A1
20120022629 Perera et al. Jan 2012 A1
20120022633 Olson et al. Jan 2012 A1
20120053680 Bolling et al. Mar 2012 A1
20120059458 Buchbinder et al. Mar 2012 A1
20120123529 Levi et al. May 2012 A1
20120150287 Forster et al. Jun 2012 A1
20120215236 Matsunaga et al. Aug 2012 A1
20120259409 Nguyen et al. Oct 2012 A1
20120283820 Tseng et al. Nov 2012 A1
20120310328 Olson et al. Dec 2012 A1
20120316643 Keranen Dec 2012 A1
20120323316 Chau et al. Dec 2012 A1
20130006352 Yaron Jan 2013 A1
20130023985 Khairkhahan et al. Jan 2013 A1
20130114214 Takeguchi et al. May 2013 A1
20130190857 Mitra et al. Jul 2013 A1
20130190865 Anderson Jul 2013 A1
20130204311 Kunis Aug 2013 A1
20130274873 Delaloye et al. Oct 2013 A1
20130310917 Richter et al. Nov 2013 A1
20130310928 Morriss Nov 2013 A1
20130317598 Rowe et al. Nov 2013 A1
20130325114 McLean et al. Dec 2013 A1
20130331929 Mitra et al. Dec 2013 A1
20140067054 Chau et al. Mar 2014 A1
20140074299 Endou et al. Mar 2014 A1
20140081394 Keranen et al. Mar 2014 A1
20140155997 Braido Jun 2014 A1
20140163669 Ben-Zvi et al. Jun 2014 A1
20140172070 Seguin Jun 2014 A1
20140194981 Menk et al. Jul 2014 A1
20140200661 Pintor et al. Jul 2014 A1
20140236287 Clague et al. Aug 2014 A1
20140277417 Schraut et al. Sep 2014 A1
20140277419 Garde et al. Sep 2014 A1
20140277424 Oslund Sep 2014 A1
20140330372 Weston et al. Nov 2014 A1
20140343671 Yohanan et al. Nov 2014 A1
20140350667 Braido et al. Nov 2014 A1
20140358222 Gorman et al. Dec 2014 A1
20140358224 Tegels et al. Dec 2014 A1
20140379074 Spence Dec 2014 A1
20140379076 Vidlund et al. Dec 2014 A1
20150025623 Granada et al. Jan 2015 A1
20150073545 Braido Mar 2015 A1
20150073546 Braido Mar 2015 A1
20150190227 Johnson et al. Jul 2015 A1
20150230921 Chau et al. Aug 2015 A1
20150245910 Righini et al. Sep 2015 A1
20150282931 Brunnett et al. Oct 2015 A1
20150335428 Keranen Nov 2015 A1
20150335430 Loulmet et al. Nov 2015 A1
20150374493 Yaron et al. Dec 2015 A1
20160015514 Lashinski et al. Jan 2016 A1
20160074165 Spence et al. Mar 2016 A1
20160095705 Keranen et al. Apr 2016 A1
20160143732 Glimsdale May 2016 A1
20160184095 Spence et al. Jun 2016 A1
20160199177 Spence et al. Jul 2016 A1
20160256276 Yaron Sep 2016 A1
20160346080 Righini et al. Dec 2016 A1
20170007399 Keranen Jan 2017 A1
20170007402 Zerkowski et al. Jan 2017 A1
20170217385 Rinkleff et al. Aug 2017 A1
20170266005 McGuckin, Jr. Sep 2017 A1
20170273788 O'Carroll et al. Sep 2017 A1
20170273789 Yaron et al. Sep 2017 A1
20170281337 Campbell Oct 2017 A1
20170360426 Hacohen et al. Dec 2017 A1
20180000580 Wallace et al. Jan 2018 A1
20180085217 Lashinski et al. Mar 2018 A1
20180206074 Tanasa et al. Jul 2018 A1
20180289481 Dolan Oct 2018 A1
20180303606 Rothstein et al. Oct 2018 A1
20180318073 Tseng et al. Nov 2018 A1
20180318080 Quill et al. Nov 2018 A1
20200054453 Zerkowski et al. Feb 2020 A1
20200360143 O'Carroll et al. Nov 2020 A1
20210212826 Zerkowski et al. Jul 2021 A1
20210361426 Hacohen Nov 2021 A1
20230086853 Zerkowski et al. Mar 2023 A1
Foreign Referenced Citations (80)
Number Date Country
1684644 Oct 2005 CN
1714766 Jan 2006 CN
101588771 Nov 2009 CN
102670332 Sep 2012 CN
19532846 Mar 1997 DE
19546692 Jun 1997 DE
19857887 Jul 2000 DE
19907646 Aug 2000 DE
0103546 Mar 1984 EP
0597967 May 1994 EP
0592410 Oct 1995 EP
0850607 Jul 1998 EP
1432369 Jun 2004 EP
1521550 Apr 2005 EP
1796597 Jun 2007 EP
1296618 Jan 2008 EP
2072027 Jun 2009 EP
1827314 Dec 2010 EP
2620125 Jul 2013 EP
2726018 May 2014 EP
2806829 Dec 2014 EP
3395296 Dec 2019 EP
2747708 Jan 2022 EP
2788217 Jul 2000 FR
2815844 May 2002 FR
2004502494 Jan 2004 JP
2008531185 Aug 2008 JP
1271508 Nov 1986 SU
9117720 Nov 1991 WO
9301768 Feb 1993 WO
9829057 Jul 1998 WO
9940964 Aug 1999 WO
9947075 Sep 1999 WO
0041652 Jul 2000 WO
0047139 Aug 2000 WO
0149213 Jul 2001 WO
0154625 Aug 2001 WO
0162189 Aug 2001 WO
0164137 Sep 2001 WO
0176510 Oct 2001 WO
0203892 Jan 2002 WO
0222054 Mar 2002 WO
0236048 May 2002 WO
0247575 Jun 2002 WO
03028558 Apr 2003 WO
03047468 Jun 2003 WO
2005034812 Apr 2005 WO
2005084595 Sep 2005 WO
2006011127 Feb 2006 WO
2006091163 Aug 2006 WO
2006111391 Oct 2006 WO
2006138173 Dec 2006 WO
2005102015 Apr 2007 WO
2007047488 Apr 2007 WO
2007067942 Jun 2007 WO
2007097983 Aug 2007 WO
2008005405 Jan 2008 WO
2008015257 Feb 2008 WO
2008058940 May 2008 WO
2008091515 Jul 2008 WO
2009033469 Mar 2009 WO
2009080801 Jul 2009 WO
2009134701 Nov 2009 WO
2009155561 Dec 2009 WO
2010057262 May 2010 WO
2010121076 Oct 2010 WO
2012063228 May 2012 WO
2013001339 Jan 2013 WO
2013068542 May 2013 WO
2013110722 Aug 2013 WO
2013114214 Aug 2013 WO
2015023579 Feb 2015 WO
2015023862 Feb 2015 WO
2015125024 Aug 2015 WO
2015127264 Aug 2015 WO
2015198125 Dec 2015 WO
2016038017 Mar 2016 WO
2016040881 Mar 2016 WO
2016130820 Aug 2016 WO
2017103833 Jun 2017 WO
Non-Patent Literature Citations (27)
Entry
Al-Khaja, et al. “Eleven Years' Experience with Carpentier-Edwards Biological Valves in Relation to Survival and Complications,” European Journal of Cardiothoracic Surgery, vol. 3. pp. 305-311. 1989.
Andersen, H.R. “History of Percutaneous Aortic Valve Prosthesis,” Herz No. 34. pp. 343-346. 2009.
Andersen, H.R., et al. “Transluminal Implantation of Artificial Heart Valve. Description of a New Expandable Aortic Valve and Initial Results with implantation by Catheter Technique in Closed Chest Pig,” European Heart Journal, No. 13. pp. 704-708. 1992.
Bailey, S. “Percutaneous Expandable Prosthetic Valves,” Textbook of Interventional Cardiology vol. 2, 2nd Ed. pp. 1268-1276. 1994.
Bonhoeffer et at., “Percutaneous Replacement of Pulmonary valve in a Right-Ventricle to Pulmonary-Artery Prosthetic Conduit with Valve Dysfunction,” Early Report, The Lancet, vol. 356, Oct. 21, 2000.
Casselman et al., “Reducing Operative Morality in Valvular Reoperations: The “valve in ring” Procedure,” Brief Technique Reports, The Journal of Thoracic and Cardiovascular Surgery, vol. 141, No. 5. May 2011.
Cheung et al, Live Case Transmissions, NYHA III CHF, Case Summary, Sep. 23, 2010, St. Paul's Hospital/ University of British Columbia.
Cheung et al, “Transapical Transcatheter Mitral Valve-in-Valve Implantation in a Human,” The Society of Thoracic Surgeons, 2009.
Descoutures et al., “Transcatheter Valve-in-Ring Implantation After Failure of Surgical Mitral Repair,” European Journal of Cardio-Thoracic Surgery 44, e8-e15, 2013.
Himbert et al., “Transseptal Implantation of a Transcatheter Heart Valve in a Mitral Annuloplasty Ring to Treat Mitral Repair Failure,” Circulation Cardiovascular Interventions, American Heart Association, 2011.
Himbert, Dominique, “Transvenous Mitral Valve Repair Replacement After Failure of Surgical Ring Annuloplasty,” Research Correspondence, Journal of the American College of Cardiology, 2012.
International Search Report from corresponding PCT case No. PCT/IB2015/000901 dated Feb. 15, 2015.
Kempfert et al., “Minimally invasive off-pump valve-in-a-ring implantation: the atrial transcatheter approach for re-operative mitral valve replacement after failed repair,” European Journal of Cardiothoracic Surgery, 2009, 35:965-969.
Ma et al., “Double-Crowned Valved Stents for Off-Pump Mitral Valve Replacement,” European Journal of Cardio-Thoracic Surgery, 28, 194-199, 2005.
Pavcnik, et al. “Development and initial Experimental Evaluation of a Prosthetic Aortic Valve for Transcatheter Placement,” Cardiovascular Radiology, vol. 183, No. 1. pp. 151-154. 1992.
Ross, “Aortic Valve Surgery,” At a meeting of the Council on Aug. 4, 1966. pp. 192-197.
Sabbah, et al. “Mechanical Factors in the Degeneration of Porcine Bioprosthetic Valves: An Overview,” Journal of Cardiac Surgery, vol. 4, No. 4. pp. 302-309. 1989.
Shuto et al., “Percutaneous Transvenous Melody Valve-in-Ring Procedure for Mitral Valve Replacement,” J Am Coll Cardiol, 58(24): 2475-2480, 2011.
Uchida, “Modifications of Gianturco Expandable Wire Stents,” American Journal of Roentgenology, vol. 150. pp. 1185-1187. 1986.
Walther et al., “Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation,” Case Reports, The Society of Thoracic Surgeons, 2008.
Walther et al., “Valve-in-a-Valve Concept for Transcatheter Minimally Invasive Repeat Xenograph Implantation,” Preclinical Studies, Journal of the American College of Cardiology, 2007.
Webb et al., “Mitral Valve in Valve,” TCT Sep. 2009, Live Case: 30 Minutes, St. Paul's Hospital/University of British Columbia.
Webb et al., “Transcatheter Valve-in-Valve Implantation for Failed Bioprosthetic Heart Valves,” Journal of the American Heart Association, 11, Apr. 27, 2010.
Weger et al., “First-in-Man Implantation of a Trans-Catheter Aortic Valve in a Mitral Annuloplasty Ring: Novel Treatment Modality for Failed Mitral Valve Repair,” European Journal of Cardio-Thoracic Surgery 39, 1054-1056, 2011.
Wenaweser et al., “Percutaneous Aortic Valve Replacement for Severe Aortic Regurgitation in Degenerated Bioprosthesis: The First Valve Procedure Using Corevalve Revalving System,” Catheterization and Cardiovascular Interventions, 70:760-764, 2007.
Wheatley, “Valve Prostheses,” Operative Surgery, 4th ed. pp. 415-424. 1986.
Walther, et al., “Trans-catheter valve-in-valve implantation: in vitro hydrodynamic performance of the SAPIEN + cloth trans-catheter heart valve in the Carpentier-Edwards Perimount valves,” European Journal of Cardio-thoracic Surgery, 40 (2011) 1120-1126, Sep. 23, 2010.
Related Publications (1)
Number Date Country
20210137678 A1 May 2021 US
Provisional Applications (1)
Number Date Country
61943125 Feb 2014 US
Continuations (2)
Number Date Country
Parent 16057192 Aug 2018 US
Child 17156265 US
Parent 14628060 Feb 2015 US
Child 16057192 US